comparemela.com

Latest Breaking News On - Kim jaffe - Page 1 : comparemela.com

BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention

BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-diego-convention-center
California
United-states
San-diego
Angus-liu
Kim-jaffe
Bluesphere-bio
Andrew-mielach
Keir-loiacono
Lifesci-communications
Panel-discussion
Head-of-business-development-strategy

BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies Conference

BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

San-diego-convention-center
California
United-states
San-diego
Bluesphere-bio
Andrew-mielach
Robert-keefe
Kim-jaffe
While-the-company
Head-of-business-development-strategy
Lifesci-communications
Company-contact

BlueSphere Bio Data to be Presented at the 2022 Joint ASTCT

PITTSBURGH, May 25, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform.

Bluesphere-bio
Sawa-ito
Andrew-mielach
Kim-jaffe
Business-development-operations
Company-contact
University-of-pittsburgh-school-medicine
High-throughput-cloning-reveals-diverse-properties
Lifesci-communications
Department-of-immunology
Hillman-cancer-center
Division-of-hematology

BlueSphere Bio Data to be Presented at the 2022 American

PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a revolutionary TCR discovery.

United-states
American
Bluesphere-bio
Sawa-ito
Andrew-mielach
Kim-jaffe
Business-development-operations
Company-contact
University-of-pittsburgh-school-medicine
Clinical-research-excluding-trials
American-association-for-cancer-research
Lifesci-communications

BlueSphere Bio to Present at the BIO CEO & Investor

PITTSBURGH, Feb. 08, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a revolutionary TCR discovery.

New-york
United-states
Bluesphere-bio
David-apelian
Andrew-mielach
Marriott-marquis
Kim-jaffe
Investor-forum
Business-development-operations
Lifesci-communications
Company-contact
Sphere-bio

vimarsana © 2020. All Rights Reserved.